103 results
Page 3 of 6
6-K
EX-99.3
lx8w iq3qek7t
17 May 22
VBL Therapeutics Reports First Quarter 2022 Financial Results
7:00am
6-K
EX-99.1
gpo4 uc6e7y1ztrfd
15 Feb 22
Current report (foreign)
4:27pm
6-K
EX-1.1
nqiguvhcloa5yx9a
11 Feb 22
Current report (foreign)
5:29pm
6-K
EX-5.1
e4o662ok0wwd9kip0 aw
11 Feb 22
Current report (foreign)
5:29pm
424B5
argm1 kn79
11 Feb 22
Prospectus supplement for primary offering
5:28pm
424B8
qneytqu1
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
vkbaley
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-1.1
8amydzobiiz
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-99.1
t7eoziq3z40 p2jw3q
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-5.1
1k7sert tu8x3m
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-4.1
zkdy bs2oi0oi
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
1glxwt1jyfwvq5sy
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
qjg90lp
9 Apr 21
Prospectus supplement for primary offering
12:00am
6-K
EX-5.1
b6y4oxf xpjruf1u
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
6-K
EX-99.1
w3zje2 ff
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
6u24e
15 Jan 21
Prospectus supplement for primary offering
7:00am